ThermoGenesis Corp. (NASDAQ: KOOL) has their focus on the regenerative medicine market. This focus inspired the company to create a wholly-owned subsidiary named Vantus Inc. This subsidiary is a veterinary stem cell laboratory service that has collaborations with the UC Davis School of Veterinary Medicine’s Center for Equine Health and its Stem Cell Regenerative Medicine group to conduct research and development to enhance the collecting, processing, and storing of stem cells. For further information, visit the Company’s web site at www.thermogenesis.com.
- 17 years ago
QualityStocks
ThermoGenesis Corp. (NASDAQ: KOOL)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Portfolio in Walker Lane Hotspot
As Nevada’s Walker Lane becomes a prime target for mineral exploration, Lahontan Gold (TSX.V: LG) (OTCQB:…
-
QualityStocksNewsBreaks – Adageis’ Platform Tackles Healthcare Complexities with AI
Adageis was featured in a recent article that discussed its powerful and patented AI-centric software solution.…
-
ONAR Holding Corp. (ONAR): In Marketing’s AI Era, Strategy is Beating Speed
ONAR's network of technology-first agencies focuses on data-driven strategy and execution over flashy, reactive campaigns…